Atropine 1% ophthalmic (eye) drops have discontinued

Recently, the Canadian manufacturers of Atropine 1% ophthalmic (eye) drops have discontinued making this product. According to a letter issued by the Canadian Ophthalmological Society, the drug is a “critical” medication. It is used in variety ophthalmic therapeutic setting to prevent blindness, glaucoma and uveitis among other conditions.

During this shortage, Clark’s has the capability, raw materials and expertise to compound atropine ophthalmic drops in different concentrations. In addition to standard drops, we are working on a preservative formulation, in order to provide as much safety and choice for patients. Our facility is ISO 9001:2015 certified while our finished products are subject to both sterility and potency standards. Call us to help manage atropine ophthalmic solution shortage. 1-888-542-8888

Click here for further info.

“Isopto Atropine 1% is widely used across ophthalmology. It is critical in preventing blindness and ensuring the best possible outcomes for patients.”